Wu Meng-Hua, Zhong Chu-Chu, Yu Pin-Hao, Li Feng, Zhang Ying, Ma Zhi-Guo, Cao Hui
Research Center for Traditional Chinese Medicine of Lingnan(Southern China), Lingnan Branch of National Engineering Research Center for Modernization of Traditional Chinese Medicine, Jinan University College of Pharmacy Guangzhou 510632, China.
Huazhou Pummelo Peel Medical Materials Development Co., Ltd. Huazhou 525100, China.
Zhongguo Zhong Yao Za Zhi. 2021 Feb;46(3):736-744. doi: 10.19540/j.cnki.cjcmm.20201121.101.
In ancient times, there were two types of "Juhong" came from the tangerines(Citrus reticulata) and the pomelos(C. grandis and its cultivars), which corresponded to Juhong and Huajuhong recorded in the Chinese Pharmacopoeia respectively. In different periods, Juhong basically came from the same species and the same medicinal parts, but there were also some differences. This article sorted out the ancient and modern literature, under the guidance of "Succession theory of Medicinal materials varieties" and "Change theory of Medicinal materials varieties"(XIE Zong-wan), and combined with field investigation, the evolution and reasons of the original plants and medicinal parts of Juhong were analyzed. In the Han Dynasty and before, the peel of tangerines and pomelos were both used as medicine. In the Southern and Northern Dynasties, the way tangerine peel was used was dried and aged, and then "soaked in hot water and scraped off the mesocarp", which had the essence of only using exocarp as medicine of Juhong already, and its original plant was C. reticalata. In the Song Dynasty, the name of "Juhong" and its medicinal usage were recorded in book on materia medica, and the species and medicinal parts of tangerine were inherited from the previous dynasties. The way tangerine peel was used was only dried and aged without removing the mesocarp. The medicinal material obtained by the way was called Chenpi(dried and aged tangerine peel). The item "Juhong" listing as a separate medicinal material was first recorded in the Collected Discussions from Materia Medica(Bencao Huiyan) in the Ming Dynasty. In the Ming Dynasty, the Dao-di habitat of Juhong was recorded as Guangdong province in most books on materia medica, and the original plants probably were C. reticalata and C. grandis 'Tomentosa'(Huazhou pomelo, a special cultivated species of C. grandis produced in Huazhou, Guangdong, which was recorded in the Chinese Pharmacopoeia as "Huajuhong"), according to the records in the local chronicles. During the Qing Dynasty and the Republic of China, the original plants of Juhong were C. reticalata and C. grandis 'Tomentosa'. Of the two, the latter one was considered as the better. As far the medicinal part, it was still the exocarp, while the whole young fruit of C. grandis 'Tomentosa' began to be used as medicine. After the founding of The People's Republic of China, the exocarps of Citrus reticalata, C. grandis and C. grandis 'Tomentosa' were listed in the Chinese Pharmacopoeia under "Juhong". From the Northern and Southern Dynasties to the Republic of China, C. grandis exocarp was a fake of Juhong. Therefore, it was contradictory to historical records that C. grandis exocarp was listed in the Chinese Pharmacopoeia as Huajuhong. Juhong had been divided into two types as "Juhong" and "Huajuhong" since 1985. The medicinal part of Huajuhong was only the exocarp of immature and nearly mature fruits, but not the whole young fruit, the actual mainstream medicinal part of Huajuhong. The results are helpful to clarify the historical evolution of species and medicinal parts of Juhong and Huajuhong. It is suggested that in the next edition of Chinese Pharmacopoeia, only C. grandis 'Tomentosa' should be included as the original plant of Huajuhong, and C. grandis should be deleted, and the young fruit should be added in the medicinal parts besides the exocarp of immature and nearly mature fruit.
在古代,有两种“橘红”分别来源于橘子(Citrus reticulata)和柚子(C. grandis及其栽培变种),它们分别对应于《中国药典》中记载的橘红和化橘红。在不同时期,橘红基本来源于同一物种和相同药用部位,但也存在一些差异。本文梳理古今文献,在“药材品种传承理论”和“药材品种变异理论”(谢宗万)指导下,结合实地考察,分析了橘红原植物及药用部位的演变及原因。汉代及以前,橘子皮和柚子皮均入药。南北朝时期,橘子皮的使用方法是晒干陈化,然后“汤浸去白”,已具备只取用橘红外果皮入药的实质,其原植物为C. reticalata。宋代,本草书籍记载了“橘红”之名及其药用方法,橘子的品种及药用部位沿袭前朝。橘子皮的使用方法只是晒干陈化,不去除中果皮。以此方法获得的药材称为陈皮(晒干陈化的橘子皮)。“橘红 ”作为独立药材条目首次记载于明代的《本草汇言》。明代,多数本草书籍记载橘红的道地产地为广东省,根据地方志记载,其原植物可能为C. reticalata和C. grandis 'Tomentosa'(化州柚,C. grandis在广东化州产出的一个特殊栽培变种,在《中国药典》中记载为“化橘红”)。清代及民国时期,橘红的原植物为C. reticalata和C. grandis 'Tomentosa'。二者之中,后者被认为更佳。至于药用部位,仍为外果皮,而化州柚的整个幼果开始入药。中华人民共和国成立后,C. reticalata、C. grandis和C. grandis 'Tomentosa'的外果皮被列入《中国药典》“橘红”项下。从南北朝至民国,C. grandis外果皮为橘红伪品。因此,C. grandis外果皮在《中国药典》中被列为化橘红与历史记载相悖。自1985年起,橘红已分为“橘红”和“化橘红”两类。化橘红的药用部位仅为未成熟和近成熟果实的外果皮,而非化橘红实际主流药用部位的整个幼果。研究结果有助于厘清橘红和化橘红品种及药用部位的历史演变。建议在下一版《中国药典》中,仅将化州柚列入化橘红的原植物,删除C. grandis,并在药用部位中除未成熟和近成熟果实外果皮外增加幼果。